Functional melanocortin 1 receptor Mc1r is not necessary for an inflammatory response to UV radiation in adult mouse skin

Experimental Dermatology

Volumn 22, Issue 3, 2013, Pages 226-228

  Wolnicka Glubisz, Agnieszka ^a,b   De Fabo, Edward ^a   Noonan, Frances ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Immune suppression; Inflammation; Mc1r; UV

Indexed keywords

CD11B ANTIGEN; MELANOCORTIN 1 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; CONTACT ALLERGY; CONTROLLED STUDY; DNA DAMAGE; FLUORESCENCE ACTIVATED CELL SORTING; IMMUNE DEFICIENCY; INFLAMMATION; LETTER; MOUSE; NONHUMAN; SKIN PIGMENTATION; SWELLING; ULTRAVIOLET RADIATION;

ALPHA-MSH; ANIMALS; ANTIGENS, CD11B; ANTIGENS, LY; DOSE-RESPONSE RELATIONSHIP, RADIATION; INFLAMMATION; KERATINOCYTES; MELANOCYTES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, ANIMAL; RECEPTOR, MELANOCORTIN, TYPE 1; SKIN; ULTRAVIOLET RAYS; UP-REGULATION;

EID: 84875036232     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12100     Document Type: Letter

References (28)

1. Slominski A, Wortsman J, Luger T et al. Physiol Rev 2000: 803: 979-1020. Review.
2. Abdel-Malek Z, Scott M C, Suzuki I et al. Pigment Cell Res 2000: 8: 156-162.
3. Rana B K, Hewett-Emmett D, Jin L et al. Genetics 1999: 151: 1547-1557.
4. Healy E, Jordan S A, Budd P S et al. Hum Mol Genet 2001: 10: 2397-2402.
5. Beaumont K A, Newton R A, Smit D J et al. Hum Mol Genet 2005: 14: 2145-2154.
6. Manna S K, Aggarwal B B. J Immunol 1998: 161: 2873-2880.
7. Kalden D H, Scholzen T, Brzoska T et al. Ann N Y Acad Sci 1999: 885: 254-261.
8. Ichiyama T, Sakai T, Catania A et al. J Neuroimmunol 1999: 99: 211-217.
9. Mason M J, Van Epps D. J Immunol 1989: 142: 1646-1651.
10. Abdel-Malek Z A. Cell Mol Life Sci 2001: 58: 434-441.
11. Loser K, Brzoska T, Oji V et al. PLoS One 2010: 5: e8958.
12. Auriemma M, Brzoska T, Klenner L et al. J Invest Dermatol 2012: 132: 1814-1824.
13. Grabbe S, Bhardwaj R S, Mahnke K et al. J Immunol 1996: 156: 473-478.
14. Getting S J, Christian H C, Lam C W et al. J Immunol 2003: 170: 3323-3330.
15. Maaser C, Kannengiesser K, Specht C et al. Gut 2006: 55: 1415-1422.
16. Portugal-Cohen M, Soroka Y, Frušić-Zlotkin M et al. Exp Dermatol 2011: 20: 749-755.
17. Chakraborty A K, Funasaka Y, Slominski A et al. Biochim Biophys Acta 1996: 1313: 130-138.
18. Wolnicka-Glubisz A, Damsker J, Constant S et al. J Leukoc Biol 2007: 81: 1352-1361.
19. Noonan F P, Hoffman H A. Immunogenetics 1994: 39: 29-39.
20. Noonan F P, Hoffman H A. Immunogenetics 1994: 40: 247-256.
21. Montero-Melendez T, Patel H B, Seed M et al. Am J Pathol 2011: 179: 259-269.
22. Skobowiat C, Dowdy J C, Sayre R M et al. Am J Physiol Endocrinol Metab 2011: 301: E484-E493.
23. Jackson I J, Budd P S, Keighren M et al. Hum Mol Genet 2007: 16: 2341-2348.
24. Slominski A, Plonka P M, Pisarchik A et al. Endocrinology 2005: 146: 1245-1253.
25. Ermak G, Slominski A. J Invest Dermatol 1997: 108: 160-165.
26. Flanagan N, Ray A J, Todd C et al. J Invest Dermatol 2001: 117: 1314-1317.
27. Smith G, Wilkie M J, Deeni Y Y et al. Br J Dermatol 2007: 157: 1230-1234.
28. Cooper A, Robinson S J, Pickard C et al. J Immunol 2005: 175: 4806-48013.